INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

18,937 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
OC
Ohlgart ChristianeChief Financial Officer
FTNTFortinet, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
756 sh
May 7, 2026May 8, 2026
traded May 7, 2026
+1dSEC Form 4

Evidence

5
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$230K
2,993 sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC Form 4

Evidence

2
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$41K
1,366 sh
May 8, 2026May 8, 2026
traded May 8, 2026
+0dSEC Form 4

Evidence

1
MA
McGuire AnnieSVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$204K
5,102 sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC Form 4

Evidence

1
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
1,054 sh
May 7, 2026May 8, 2026
traded May 7, 2026
+1dSEC Form 4

Evidence

1
SL
Schwartz LarissaSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$181K
2,330 sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC Form 4

Evidence

1
MA
McGuire AnnieSVP, General Counsel
VCYTVERACYTE, INC.
Open-market sale · 10b5-1 plan
SELL$194K
5,102 sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC Form 4

Evidence

0
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$3,703
118 sh
May 8, 2026May 8, 2026
traded May 8, 2026
+0dSEC Form 4

Evidence

0
SM
Smith Chad M.Pres & COO, Better Mortgage
BETRBetter Home & Finance Holding Co
Open-market sale · 10b5-1 plan
SELL$30K
971 sh
May 8, 2026May 8, 2026
traded May 8, 2026
+0dSEC Form 4

Evidence

57
DB
Denton BlakeSVP, Marketing & Contracts
NENoble Corp plc
Open-market sale
SELL$1.48M
30.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

53
KM
Kawaja Joey MSVP, Operations
NENoble Corp plc
Open-market sale
SELL$1.99M
40.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

48
PD
Porter John DeanEVP & CFO
WMBWILLIAMS COMPANIES, INC.
Open-market sale
SELL$3.77M
50.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

47
WY
Wang Chia YuanSenior management
GGBGERDAU S.A.
Open-market sale
SELL$190K
40.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
DJ
Deegan Brian JohnGroup Chief Accounting Officer
HGHamilton Insurance Group, Ltd.
Open-market sale
SELL$338K
11.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
GQ
Guo Jack Q.EVP & CFO
CSTMCONSTELLIUM SE
Open-market sale
SELL$822K
25.2K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
HJ
Holt Adrian JamesSVP, Chf HR Ofcr
EMNEASTMAN CHEMICAL CO
Open-market sale
SELL$132K
1,709 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

36
CL
Campbell Renee LSVP, Capital Markets & Risk
VMIVALMONT INDUSTRIES INC
Open-market sale
SELL$215K
412 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

36
NM
Norsa MicheleDirector
ZGNErmenegildo Zegna N.V.
Open-market sale
SELL$47K
4,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

30
BL
Brown Claude LeonardChief Business Officer
PINSPINTEREST, INC.
Open-market sale
SELL$1.27M
61.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

30
CM
Chan MitchellDirector
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$72K
3,167 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$426K
19.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

29
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$953K
44.9K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

28
JC
Jaime CesarDirector
PTENPATTERSON UTI ENERGY INC
Open-market sale
SELL$123K
10.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

28
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$123K
3,000 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

26
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$201K
8,900 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

26
GP
Gallagher Thomas P.Director, Chairman & CEO
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Open-market sale · 10b5-1 plan
SELL$756K
15.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

26
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$230K
10.1K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
NM
Neagle MatthewChief Operating Officer
PRCHPorch Group, Inc.
Open-market sale
SELL$634K
60.8K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

25
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
13.8K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

25
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$496K
27.5K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

24
RF
Robin Jodi F.General Counsel and Secretary
TRSTRIMAS CORP
Open-market sale
SELL$83K
2,000 sh
May 7, 2026May 7, 2026
traded May 7, 2026
+0dSEC Form 4

Evidence

23
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$47K
15.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$238K
12.3K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

22
TS
Tabak ShawnCHIEF FINANCIAL OFFICER
PRCHPorch Group, Inc.
Open-market sale
SELL$111K
10.6K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

22
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$197K
9,219 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

21
VJ
Viana Antonio JDirector
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$601K
20.0K sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

19
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$27K
1,679 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

18
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$56K
2,700 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

18
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$98K
5,000 sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC Form 4

Evidence

13
SJ
Sellers JeanetteSVP of Accounting
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
3,695 sh
May 5, 2026May 7, 2026
traded May 5, 2026
+2dSEC Form 4

Evidence

Page 251 of 474
← PrevNext →